|
|
REGISTER NOW!
DATE:
FRIDAY, 22 AUGUST 2025
|
Time:
|
| 10:00 – 11:00 HRS |
Male |
| 10:30 – 11:30 HRS |
Mumbai · Colombo |
| 11:00 – 12:00 HRS |
Dhaka |
| 12:00 – 13:00 HRS |
JKT · BKK · HCMC |
| 13:00 – 14:00 HRS |
SG · KL · Manila · Taipei |
| 14:00 – 15:00 HRS |
Seoul |
| 15:00 – 16:00 HRS |
Sydney |
| 17:00 – 18:00 HRS |
Auckland |
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide.
Effective surveillance and early detection in those with high risk are crucial for improving patient outcomes. Traditional methods like abdominal ultrasound and alpha-fetoprotein (AFP) testing have been widely used. However, the sensitivity of ultrasound and AFP for HCC detection can be compromised by the severity of liver disease, particular etiologies of liver disease (MASLD), and high BMI.
This webinar aims to explore the advancements in HCC surveillance, focusing on the role of biomarker, PIVKA-II, and the algorithm, ASAP model, to enhance HCC management.
SPEAKER |
 |
ASSOC. PROF. APICHAT KAEWDECH, MD
Medical instructor at Gastroenterology
and Hepatology Unit
Prince of Songkla University
Thailand
|
MODERATOR
|
 |
DR. KITTICHOTE DUANGNUM, MD
Assistant Medical Director
Core Diagnostics at Abbott
Thailand |
If you are already registered for this webcast, please login via the link below:
CORELABORATORY.ABBOTT
© 2025 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. For the use of registered medical practitioners, hospitals or laboratories only. CORE-25042789| 07/25
|
|
Salutation (Ms. / Mr. / Dr. / Prof.)
|
|
First Name
|
|
Last Name
|
|
Position
|
|
Hospital / Institution
|
|
Country
|
|
Email Address
|
LEGAL NOTICE
1. This meeting is intended only for individuals or entities who have been /requested to attend. If you are not such an attendee do not attempt to join this meeting. You may not disseminate, distribute or copy any information contained herein.
2. For all attendees/registrants, by clicking on either or both of the checkboxes next to the following statements, and on “Register Now” below:
|
| You accept and agree to Abbott’s Terms of Use and Privacy Policy (if necessary to find the appropriate policies for your country of residence, please click on the link to other country sites in the first paragraph of the policies linked to here; links to country-specific Terms of Use and Privacy Policies can be found at the bottom of any page of the various Abbott country websites). Specifically, you provide your clear consent to: (i) Abbott’s collection, use, transfer, and/or processing of any of your personal information provided hereunder, for the purposes of this and/or future meeting(s); (ii) Abbott’s recording of this meeting in any format, including its perpetual right to store, transmit and use such recordings for any internal or external purpose(s). |
 |
Abbott’s Terms of Use and Privacy Policy |
|
3. You may access and/or correct your personal information in the form and manner as set out in Abbott’s Privacy Policy. |
|
| You agree to be contacted via email messages by Abbott, its affiliates, contractors/sub-contractors in relation to the marketing of Abbott’s products and/or services. |
|
|
| Yes, I would like to receive information on events and offerings from Abbott |
|
|
|
|
|
|